TGF-beta receptor I conditional knockout mice develop spontaneous squamous cell carcinoma

Yasuyuki Honjo1, Yansong Bian, Koji Kawakami

  • 1Functional Genomics Section, Laboratory of Cellular and Developmental Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA.

Insights

Loss of TGF-beta receptor I in neurons causes spontaneous squamous cell carcinomas (SCCs) in mice. These tumors show immune evasion and respond to targeted therapies, offering a new SCC research model.

Area of Science:

  • Oncology
  • Immunology
  • Neuroscience

Background:

  • Transforming growth factor-beta (TGF-beta) signaling is crucial in development and disease.
  • Dysregulation of TGF-beta signaling is implicated in various cancers.
  • The role of neuronal TGF-beta signaling in tumorigenesis remains largely unexplored.

Purpose of the Study:

  • To investigate the role of neuronal TGF-beta signaling in tumor development.
  • To establish a novel mouse model for studying spontaneous squamous cell carcinomas (SCCs).
  • To explore the potential involvement of immune evasion in SCC formation and therapeutic strategies.

Main Methods:

  • Generated a conditional knockout (COKO) mouse model by crossing TbetaRI floxed mice with NF-H Cre mice.
  • Assessed spontaneous tumor development in COKO mice.
  • Evaluated tumorigenicity via transplantation into athymic nude mice.
  • Analyzed expression of interleukin-13 receptor alpha2 (IL-13R alpha2) in tumors.
  • Tested sensitivity of SCCs to IL-13R-directed cytotoxin treatment.

Main Results:

  • 35% of COKO mice developed spontaneous SCCs in periorbital/perianal regions.
  • Transplanted SCCs exhibited 62% tumorigenicity.
  • 33% of COKO tumors expressed IL-13R alpha2, a marker for immune evasion.
  • SCCs expressing IL-13R alpha2 were sensitive to IL-13R-directed cytotoxins.

Conclusions:

  • Conditional deletion of TbetaRI in neurons leads to spontaneous SCC formation.
  • This mouse model facilitates the study of SCC tumorigenesis and immune evasion.
  • The findings highlight the potential of targeting IL-13R alpha2 in SCC treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...